SEARCH BY NAME

BROWSE

Browse Australian delisted companies

0-9A BC DE F GH IJ KL MN OP QR ST UV WX YZ

Browse terminated Australian managed funds

0-9A BC DE FGH IJ KL MN OP QR ST UV WX YZ

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

QRXPHARMA LTD (QRX)

Delisted from ASX 23/05/2018

SHARE PRICES

Former (or subsequent) names

 

Shareholder links

Our website ranking of QRX: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:
Link Market Services, Rhodes Corporate Park, 1A Homebush Bay Drive, Rhodes NSW 2138
Tel : +61 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail

Company details

ISIN: w
Address: Suite 201, 697 Burke Road, Camberwell VIC 3124
Tel:  +61 3 9092 0475 Fax: +61 2 8920 0314

Date first listed: 25/05/2007
Company Secretary: Cameron Jones
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: The Company is a clinical stage specialty pharmaceutical company focused on developing and commercialising therapies to treat disorders of the central nervous system
delisted from the commencement of trading on Wednesday, 23 May 2018 pursuant to Listing rule 17.1223/05/2018
we understand the company failed and is in administration - ASX removed the company from listing as its securities have not been quoted for three years23/05/2018
shareholders in this company should consider the possibility of crystallising a capital loss in 2017/18 by selling their worthless shares, which they can achieve online by entering transaction details here - background and rationale may be viewed here11/04/2018
Under listing rule 17.6, any entity (if not already suspended) that had not paid its annual listing fees by close of business on Monday 22 August 2016 will have its securities suspended from official quotation before the commencement of trading on Tuesday 23 August 2016. The company has not paid its annual listing fees in respect of the year ending 30 June 2017 but the securities are already suspended from official quotation. 23/08/2016
The securities of QRxPharma Limited will be suspended from quotation immediately, pending the appointment of sufficient directors to comply with section 201A(2) of the Corporations Act 2001. Security Code: QRX22/05/2015
company placed into Voluntary Administration and has appointed Timothy Heesh and Amanda Lott of TPH Insolvency to act as Joint and Several Administrators22/05/2015
the suspension of trading in the securities of QRxPharma Limited will be lifted immediately, following receipt of an announcement in respect of a fully underwritten placement and rights issue16/11/2009
the securities of QRxPharma Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement in relation to a proposed capital raising13/11/2009

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.
Loading comments....  Most recent comments

When is this company going to be fully delisted

09/08/2017 09:13:18

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

     

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Edward RudnicCEO14/02/2012
    Christopher CampbellCFO01/03/2007
    John RainbowDirector11/10/2016
    Tim HeeshDirector11/10/2016

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Bruce HancoxDirector09/07/201411/10/2016
    Richard TreagusDirector09/07/201411/10/2016
    Peter CampbellDirector27/04/200711/07/2014
    Michael QuinnDirector19/09/200211/07/2014
    Peter FarrellChairman27/04/200709/07/2014
    Gary PaceDirector19/09/200209/07/2014
    John HoladayManaging Director, CEO27/04/200702/05/2014

    Date of first appointment, title may have changed.